News

Deal Announcements

Immunone Secures Debt Venture Capital

Monday, March 24, 2014 5:54:00 AM PDT | VentureDeal
   Wynnewood, PA  --  Biotechnology company Immunone has garnered $535,000 in venture debt investment, according to a regulatory filing.

Immunone is developing a "native, human antibody platform which enables us to harness the natural curative power of the human immune system."

Investors in the financing weren't disclosed in the filing.

Immunone is still seeking $65,000 in additional debt financing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1